FDA To Investigate Bone Drugs' Effects On Heart

Law360, New York (October 2, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration said on Monday that it is investigating the possible risk of developing an irregular heart rhythm when taking a class of drugs known as bisphosphonates, which are used to treat bone diseases.

The FDA said in a public statement that is investigating whether the drugs, used to treat osteoporosis and to encourage bone regrowth in cancer patients, cause a type of cardiac arrhythmia known as atrial fibrillation. The condition is not fatal by itself but may cause discomfort and increase...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.